EUVIMEDEUVIMED entdecken
Kohortenstudie

Why do patients with pheochromocytomas/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study

Yue Zhou, Yinghan Chen, Wenqian Zhang, Yunying Cui, TianYi Li, Yu Wang, Ming Li, Anli Tong iD

Endocrine · 2024

DOI: 10.1007/s12020-024-04094-7 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Endocrine, 2024. Verfasst von Yue Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical Coll…. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Catecholamines, Metanephrine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Inconsistent elevation of catecholamines (CAs) and metanephrines (MNs) was observed in pheochromocytomas/paragangliomas (PPGLs). This study aimed to explore its potential causes and report the diagnostic efficacy of MNs and CAs in a large Chinese PPGL cohort. METHODS: Clinical data and results of hormone tests were retrospectively collected. The sensitivity of plasma MNs and 24h-urinary CAs was analyzed. Clinical characteristics were compared between patients with positive and negative biochemical results, and among those with inconsistent elevation of MNs and CAs. RESULTS: Seven hundred and three patients were included, with a median onset age of 41.0 years. Plasma MNs (93% ~ 99%) showed prior diagnostic sensitivity to 24h-urinary CAs (74% ~ 89%). Patients with negative biochemical results presented as a smaller tumor (1.7 cm vs. 4.3 cm, P = 0.001), a higher proportion of normal blood pressure (60.0% vs. 20.5%, P = 0.002) and negative 131I-meta-iodobenzylguanidine (131I-MIBG) imaging (55.6% vs. 17.3%, P = 0.012). An earlier age of onset (40.0 vs. 41.0 vs. 44.5 years, P = 0.025), a higher proportion of paroxysmal hypertension (36.5% vs. 29.2% vs. 32.2%, P = 0.005) and the Epinephrine secretion type (79.3% vs. 37.7% vs. 48.0%, P 2. CONCLUSIONS: Plasma MNs exhibited a superior sensitivity than 24-h-urinary CAs in the Chinese PPGL diagnosis. Patients with a small tumor, normal blood pressure and negative 131I-MIBG imaging were prone to express negative biochemical levels. Additionally, an obvious elevation of 24-h-urinary CAs than plasma MNs was correlated to paroxysmal hypertension and the Epinephrine type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsCatecholaminesMetanephrineParagangliomaHumansAdultFemaleMaleMiddle AgedRetrospective StudiesChinaCohort StudiesYoung AdultAgedEast Asian People

Stichwörter der Autor:innen

CatecholaminesDiagnosisMetanephrinesNegative resultsPheochromocytomas/paragangliomasSensitivity

Substanzen

CatecholaminesMetanephrine

Autor:innen und Institutionen

  • Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical…
  • Department of Endocrinology, Chifeng Municipal Hospital, Chifeng, China.
  • Department of Endocrinology, The First Affiliated Hospital of North University of Hebei, North University of Hebei, Zhangjiakou, China.
  • Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Anli Tong

Förderung

  • National High Level Hospital Clinical Research Funding
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Y., Chen, Y., Zhang, W., Cui, Y., Li, T., Wang, Y., Li, M., & Tong, A. (2024). Why do patients with pheochromocytomas/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study. Endocrine. https://doi.org/10.1007/s12020-024-04094-7

Vancouver

Zhou Y, Chen Y, Zhang W, Cui Y, Li T, Wang Y, et al. Why do patients with pheochromocytomas/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study. Endocrine. 2024. doi:10.1007/s12020-024-04094-7

BibTeX
@article{Zhou2024,
  author = {Zhou, Yue and Chen, Yinghan and Zhang, Wenqian and Cui, Yunying and Li, TianYi and Wang, Yu and Li, Ming and Tong, Anli},
  title = {Why do patients with pheochromocytomas/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study},
  journal = {Endocrine},
  year = {2024},
  doi = {10.1007/s12020-024-04094-7}
}
Kostenlos starten →